GE HealthCare Technologies. has been granted a patent for an ultrasound system featuring a single flexible transducer designed to acquire scan data from multiple fetuses in a single uterus. The system includes a processor that determines each fetus’s location and heart rate using advanced data processing techniques. GlobalData’s report on GE HealthCare Technologies gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on GE HealthCare Technologies, Nucleoside chemical synthesis was a key innovation area identified from patents. GE HealthCare Technologies's grant share as of July 2024 was 47%. Grant share is based on the ratio of number of grants to total number of patents.
Ultrasound system for fetal heart rate monitoring and location
The patent US12070352B2 describes an advanced ultrasound system designed for monitoring multiple fetuses within a single uterus. Central to this system is a single transducer that features a flexible substrate and an array of transducer elements. This configuration allows the transducer to be positioned on the abdomen of a subject, enabling the acquisition of scan data. The system's processor is responsible for analyzing this data to determine the location and fetal heart rates of each fetus by applying Doppler shifts. Notably, the processor can sequentially activate different subsets of transducer elements to capture sub-aperture full matrix capture (FMC) data, which is then reconstructed to ascertain the precise locations of the fetuses before calculating their heart rates.
Additionally, the ultrasound system is capable of monitoring the maternal heart rate and adjusting the focusing and timing of data acquisition to maintain accurate tracking of the fetuses, even if they move, without needing to reposition the transducer. The flexible substrate may consist of a stretchable mesh, designed with openings to facilitate easy adjustment along the subject's abdomen. The transducer can connect to the processor through either wired or wireless means, enhancing its usability in clinical settings. Overall, this innovative ultrasound system aims to improve the monitoring of fetal health by providing real-time data on multiple fetuses simultaneously.
To know more about GlobalData’s detailed insights on GE HealthCare Technologies, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
